KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Debt to Equity: 2009-2015

Historic Debt to Equity for Novavax (NVAX) over the last 5 years, with Sep 2015 value amounting to $0.00.

  • Novavax's Debt to Equity was N/A to $0.00 in Q3 2015 from the same period last year, while for Sep 2015 it was $0.00, marking a year-over-year change of. This contributed to the annual value of $0.00 for FY2014, which is 65.18% down from last year.
  • Per Novavax's latest filing, its Debt to Equity stood at $0.00 for Q3 2015, which was down 68.10% from $0.00 recorded in Q2 2015.
  • Novavax's 5-year Debt to Equity high stood at $0.03 for Q3 2012, and its period low was $0.00 during Q3 2015.
  • Moreover, its 3-year median value for Debt to Equity was $0.00 (2014), whereas its average is $0.01.
  • As far as peak fluctuations go, Novavax's Debt to Equity surged by 363.16% in 2012, and later tumbled by 86.01% in 2015.
  • Quarterly analysis of 5 years shows Novavax's Debt to Equity stood at $0.01 in 2011, then spiked by 128.17% to $0.01 in 2012, then slumped by 61.14% to $0.00 in 2013, then crashed by 65.18% to $0.00 in 2014, then crashed by 86.01% to $0.00 in 2015.
  • Its Debt to Equity was $0.00 in Q3 2015, compared to $0.00 in Q2 2015 and $0.00 in Q1 2015.